Cytokinetics
CYTK
$48.74
Share price
3.04%
Change (1 day)
116.62%
Change (1 year)
Categories
Market capitalization of Cytokinetics (CYTK)
Market cap: $4.17 Billion
As of June 2022 Cytokinetics has a market cap of $4.17 Billion. This makes Cytokinetics the world's 2466th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Cytokinetics from 2004 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $4.04 B | 5.21% |
| 2021 | $3.84 B | 161.54% |
| 2020 | $1.47 B | 134.27% |
| 2019 | $0.62 B | 81.55% |
| 2018 | $0.34 B | -21.25% |
| 2017 | $0.43 B | -11.01% |
| 2016 | $0.49 B | 19.19% |
| 2015 | $0.41 B | 33.7% |
| 2014 | $0.30 B | 55.27% |
| 2013 | $0.19 B | 112.11% |
| 2012 | $0.09 B | 35.5% |
| 2011 | $0.06 B | -50.38% |
| 2010 | $0.13 B | -21.58% |
| 2009 | $0.17 B | 25.28% |
| 2008 | $0.14 B | -38.94% |
| 2007 | $0.23 B | -28% |
| 2006 | $0.32 B | 84.41% |
| 2005 | $0.17 B | -36.2% |
| 2004 | $0.27 B |
End of Day market cap according to different sources
On Jun 28th, 2022 the market cap of Cytokinetics was reported to be:
$4.05 Billion
$4.05 Billion
$3.99 Billion
$4.05 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $131.10 B | 3,040.56% | 🇺🇸 USA |
 Trevena TRVN | $0.06 B | -98.37% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $1.49 B | -64.26% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.01 B | -99.74% | 🇺🇸 USA |
 Array Technologies ARRY | $1.60 B | -61.55% | 🇺🇸 USA |